Therefore, we defined a subset of G-CIMP-low tumors that acquire a stem cell-like phenotype upon first recurrence, suggesting that a stem cell-like aggressive tumor behavior may exist within IDH mutant non-Codel and contribute to their resistance to adjuvant therapy and relapse as the G-CIMP-low phenotype (Figure 2A). This evidence concerns the gene IDH2 and neoplasm.